Curanex Pharmaceuticals Common Stock

CURX | NASDAQ

$5.29

+$0.35 (+7.09%)

At close: Oct 30, 2026, 3:59 PM ET

$5.10

-$0.19 (-3.63%)

Pre-market: Nov 2, 2026, 4:00 AM ET

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023
Net Income	-4.23M	-361.51K	-19.2K
Depreciation & Amortization	79.4K	n/a	1.82K
Stock-Based Compensation	n/a	n/a	n/a
Other Working Capital	-6.33M	-273.75K	14.28K
Other Non-Cash Items	-2.57K	74.68K	n/a
Deferred Income Tax	n/a	n/a	n/a
Change in Working Capital	-6.34M	-268.75K	17.26K
Operating Cash Flow	-10.48M	-555.58K	-120
Capital Expenditures	n/a	5	n/a
Cash Acquisitions	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	-346.5K	n/a	3K
Financial Cash Flow	15.31M	630.1K	72.06K
Net Cash Flow	4.82M	74.53K	71.94K
Free Cash Flow	-10.48M	-555.58K	-120
Adj. Free Cash Flow	-10.48M	-555.58K	-120
Maintenance CapEx	n/a	n/a	n/a
Growth CapEx	n/a	5	n/a
Owner Earnings	-10.48M	-555.58K	-120